Omada Health, Inc.: stock overview

OMDANASDAQHealthcare · Services-Health Services

Price

$14.33

November 13, 2026Market cap $889M

What Ploutos Investor adds for Omada Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

In short

Omada Health had revenue of $333M over the last 12 months and net income of $14M, a net margin of 4.2%. Revenue grew by 45.6% a year on average over the last 2 years. At $14.33 the shares trade at a P/E of 63.4. It holds more cash than debt, by $243M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$889M
62.04M shares
P/E
63.4
Revenue, 12 months
$333M
+45.6% a year over 2 years
Net margin
4.2%
2025: -4.9%, above 39% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

+45.6% a year over 2 years

  • 202510-K
    Revenue$260M
  • 2024
    Revenue$170M
  • 2023
    Revenue$123M

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 
$889M
Enterprise value 
$646M
P/E 
63.4
EV / EBIT 
94.0
EV / Revenue 
1.9
P/B 
3.3
FCF yield 
3.2%
Earnings yield 
1.6%

Profitability

Gross margin 
70.7%
Operating margin 
2.1%
Net margin 3-year median: -27.8%
4.2%
ROIC 
2.3%
ROIC, 5-year average 
-4.1%
ROE 
5.8%

Growth

Revenue, yearly change 
+53.2%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
+45.6%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$243M
Total debt 
$0
Net cash 
$243M
Net debt / EBITDA 
-19.7x
Interest cover 
22.4x
Current ratio 
4.18

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+622.4%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).

Gross margin

65.7%

Above 66% of the 25 companies in its industry, and 83% of all.

Operating margin

-4.6%

Above 35% of the 62 companies in its industry, and 26% of all.

Net margin

-4.9%

Above 39% of the 68 companies in its industry, and 24% of all.

ROE

-5.6%

Above 34% of the 58 companies in its industry, and 23% of all.

ROA

-4.2%

Above 31% of the 69 companies in its industry, and 22% of all.

Revenue growth

53.2%

Above 95% of the 68 companies in its industry, and 95% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Omada Health, Inc.
Exchange
NASDAQ
Industry (SIC)
8000 · Services-Health Services
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
62.04M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Omada Health's filings show?

These are Omada Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about OMDA

Didn't find what you were looking for?

Ask us
What is OMDA's market cap?

Omada Health, Inc.'s market cap is $889M, at a price of $14.33 on November 13, 2026 and 62.04M shares.

What is OMDA's P/E?

OMDA's P/E is 63.4, on earnings per share of $0.23 over the last 12 months.

How much revenue does OMDA have?

Omada Health had revenue of $333M over the last 12 months. Over the last 2 years it changed by +45.6% a year on average.

Does OMDA pay a dividend?

No. Omada Health paid no regular dividend over the last 12 months.

Where do the figures come from?

From Omada Health, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.